E. Estlin

发表

Clinical and cellular pharmacology in relation to solid tumours of childhood.

G. Veal, E. Estlin, E. Estlin, 2003, Cancer treatment reviews.

The role of pharmacokinetic and pharmacodynamic studies in the planning of protocols for the treatment of childhood cancer.

E. Estlin, S. Lowis, G. Burke, 1999, Cancer treatment reviews.

Consolidation therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of cytosine arabinoside, epipodophyllotoxins and cyclophosphamide.

E. Estlin, S. Yule, S. Lowis, 2001, Cancer treatment reviews.

THE CLINICAL A ND C ELLULAR PHARMACOLOGY O F V INCRISTINE, C ORTICOSTEROIDS, l-ASPARAGINASE, A NTHRACYCLINES a nd CYCLOPHOSPHAMIDE I N R ELATION TO CHILDHOOD ACUTE LYMPHOBLASTIC L EUKAEMIA

E. Estlin, 2000 .

The Clinical and Cellular Pharmacology Of Vincristine, Corticosteroids, l‐Asparaginase, Anthracyclines and Cyclophosphamide In Relation To Childhood Acute Lymphoblastic Leukaemia

E. Estlin, S. Yule, G. Burke, 2000, British journal of haematology.

Practicalities and ethics of running clinical trials in paediatric oncology - the UK experience.

E. Estlin, S. Ablett, 2001, European journal of cancer.

Diffuse brainstem gliomas in children: should we or shouldn't we biopsy?

E. Estlin, D. Coope, I. Kamaly-Asl, 2008, British journal of neurosurgery.

Remission induction therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase and anthracyclines.

E. Estlin, S. Lowis, G. Burke, 2001, Cancer treatment reviews.

Continuing therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of methotrexate, 6-mercaptopurine and 6-thioguanine.

E. Estlin, E. Estlin, 2001, Cancer treatment reviews.

Biochemical changes and cytotoxicity associated with methionine depletion in paediatric central nervous system tumour cell lines.

I. Podmore, E. Estlin, A. McGown, 2009, Anticancer research.

Preclinical efficacy of the bioreductive alkylating agent RH1 against paediatric tumours

D. Hussein, T. Ward, C. Dive, 2009, British Journal of Cancer.

Optimizing antimetabolite‐based chemotherapy for the treatment of childhood acute lymphoblastic leukaemia

A. Hall, E. Estlin, S. Lowis, 2000, British journal of haematology.

The cellular adaptations to hypoxia as novel therapeutic targets in childhood cancer.

J. Adamski, E. Estlin, G. Makin, 2008, Cancer treatment reviews.

Clinical Trials Involving Children with Cancer – Organizational and Ethical Issues

E. Estlin, S. Ablett, 2010 .

A feasibility study of enhanced occupational therapy for children and young people with central nervous system tumours – outcomes for the families and for occupational therapy

J. Keane, P. Bowyer, B. Pizer, 2020 .

Novel targets for therapy in paediatric oncology.

E. Estlin, 2002, Current Drug Targets - Immune, Endocrine & Metabolic Disorders.

Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group.

M. Stevens, C. R. Pinkerton, I. Lewis, 1998, British Journal of Cancer.